2014•Unpublished venueRequires access

18. Prevalence and predictors of periconceptional folic acid use

Richard P. Deane, D.J. Murphy

Open publisher page 0 citations

Abstract

The benefits of periconceptional folic acid supplementation in prevention of neural tube defects are well established. However, use of periconceptional folic acid remains disappointingly low despite clear evidence of benefit – typically less than one-third of women actually take periconceptional folic acid supplements. This chapter considers the many factors influencing the prevalence of periconceptional folic acid use – demographic, socioeconomic, lifestyle, gynaecological, previous pregnancies, current pregnancies, other medical conditions and access to folic acid supplements. The importance of underlying awareness and knowledge is discussed, including the various sources of information. The role that these factors may have in shaping future strategies to promote folic acid supplementation is also considered.

About this research paper

What this paper is about

The benefits of periconceptional folic acid supplementation in prevention of neural tube defects are well established. However, use of periconceptional folic acid remains disappointingly low despite clear evidence of benefit – typically less than one-third of women actually take periconceptional folic acid supplements. This chapter considers the many factors influencing the prevalence of periconceptional folic acid use – demographic, socioeconomic, lifestyle, gynaecological, previous pregnancies, current pregnancies, other medical conditions and access to folic acid supplements. The importance of underlying awareness and knowledge is discussed, including the various sources of information. The role that these factors may have in shaping future strategies to promote folic acid supplementation is also considered.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The benefits of periconceptional folic acid supplementation in prevention of neural tube defects are well established. However, use of periconceptional folic acid remains disappointingly low despite clear evidence of benefit – typically less than one-third of women actually take periconceptional folic acid supplements. This chapter considers the many factors influencing the prevalence of periconceptional folic acid use – demographic, socioeconomic, lifestyle, gynaecological, previous pregnancies, current pregnancies, other medical conditions and access to folic acid supplements. The importance of underlying awareness and knowledge is discussed, including the various sources of information. The role that these factors may have in shaping future strategies to promote folic acid supplementation is also considered.

Key concepts: Folic acid, Folic acid supplementation, Medicine, Neural tube defect, Neural tube, Pregnancy, Socioeconomic status, Obstetrics

Related papers

Back to paper searchBrowse research topicsOriginal source
18. Prevalence and predictors of periconceptional folic acid use — Research Paper | ScholarLens